Evaluation of the Effect of the Dietary Supplement X34 on Skin Radiance of Healthy Volunteers With Dull Complexion

September 20, 2016 updated by: Nutratech Conseils
The main objective of this trial is to evaluate the effect of the daily dose of X34 dietary supplement on skin radiance (clinical assessment) for 8 weeks.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

35

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Female volunteers:
  • Age: 40-70 years
  • Who have a dull complexion evaluated by clinical scoring
  • Phototype II to IV (annex 5)
  • Non-smoking or smoking less than 5 cigarettes per day
  • Did not change her eating habits, within one month before the start of the study and agreeing not change during the study
  • With no history of facial skin care (peeling, mask…) 15 days before the beginning of the study and agreeing not to perform during the study
  • Volunteers accepting not changing their local treatment on face
  • Who agree to avoid UV exposure (sun or tanning booth) during the study
  • Who have a fixed address and are entitled to Social Security or a similar National Insurance scheme
  • Who sign a written informed consent

Exclusion Criteria:

  • Pregnant, nursing, or intending to become pregnant in the course of the study
  • With a history of allergy or hypersensitivity to the products or one of their components
  • Having use oral nutritional supplements and/or vitamin supplementation less than one month before and/or refusing not consuming nutritional supplement during the study
  • Having used cosmetics and/or topical preparations containing ingredients claiming efficacy on skin radiance less than 15 days before and/or during the study
  • With a dermatosis, systemic disease or treatment susceptible to interfere with the evolution of the parameters of the study or with taking the nutritional supplement
  • Participation in another clinical trial evaluating skin radiance during the last month before the study
  • Participation in another clinical trial or volunteers being in the exclusion phase of such a trial, thus being unable to participate in any other one
  • Who have forfeited their freedom by judiciary decision or are deemed legally incompetent
  • Having perceived more than 4500 € as indemnification fees for participation in clinical trials during the preceding 12 months (including participation in this clinical trial)
  • Unable to comply with the protocol constraints
  • Who cannot be contacted by phone rapidly

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: X34
Arm supplemented with X34
Dietary supplement named X34

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Skin radiance: clinical scoring
Time Frame: At 0 week and 8 weeks
At 0 week and 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subject self-assessments
Time Frame: At 0 week and 8 weeks
Subjects will evaluate the radiance of their complexion by self-assessment.
At 0 week and 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2014

Primary Completion (Actual)

March 1, 2016

Study Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

January 16, 2015

First Submitted That Met QC Criteria

January 22, 2015

First Posted (Estimate)

January 28, 2015

Study Record Updates

Last Update Posted (Estimate)

September 21, 2016

Last Update Submitted That Met QC Criteria

September 20, 2016

Last Verified

March 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • DE-87

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Volunteers

3
Subscribe